Motilal Oswal Alternates has made a $72 million investment in Sensa Core Medical Instrumentation to support growth in the medical devices sector. The private equity arm took a significant minority stake in the Hyderabad-based company. The funding will help Sensa Core speed up product development, expand production and grow its global footprint
Sensa Core was founded in 2006 and focuses on the design, development, manufacturing and distribution of in-vitro diagnostic devices. Its products include electrolyte analysers, glucometers and haemoglobin meters, which are used in more than 40,000 hospitals and diagnostic labs in India. The company also exports its products to more than 78 countries.
The investment comes as India works to reduce dependence on imported medical devices. Currently, more than 75% of devices used in the country are brought from abroad. The new capital will also support a new manufacturing facility at the Medical Device Park in Sultanpur, Hyderabad, aimed at scaling capacity and developing next-gen devices.
Company leaders say the deal reflects confidence in Sensa Core’s plans to lead homegrown healthcare innovation and help improve affordable healthcare access in India and beyond.
#ProductDevelopment
#MotilalOswalAlternates
#SensaCore
#MedicalDevices
#StartupFunding
#InVitroDiagnostics
#HealthcareInnovation
#HyderabadTech
#GlobalExpansion
#DiagnosticEquipment
#HealthcareManufacturing
